277 related articles for article (PubMed ID: 20188422)
1. Presence and predictors of pain in depression: results from the FINDER study.
Demyttenaere K; Reed C; Quail D; Bauer M; Dantchev N; Montejo AL; Monz B; Perahia D; Tylee A; Grassi L
J Affect Disord; 2010 Sep; 125(1-3):53-60. PubMed ID: 20188422
[TBL] [Abstract][Full Text] [Related]
2. Relationships among pain, anxiety, and depression in primary care.
Means-Christensen AJ; Roy-Byrne PP; Sherbourne CD; Craske MG; Stein MB
Depress Anxiety; 2008; 25(7):593-600. PubMed ID: 17932958
[TBL] [Abstract][Full Text] [Related]
3. [Results of the French cohort of the European observational study FINDER: quality of life of patients treated with antidepressants].
Dantchev N; Tcherny-Lessenot S; Picard H; Baraille L; Quail D
Encephale; 2013 Apr; 39(2):101-8. PubMed ID: 23095580
[TBL] [Abstract][Full Text] [Related]
4. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
[TBL] [Abstract][Full Text] [Related]
5. Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: prevalence of painful somatic symptoms, functioning and health status.
Romera I; Fernández-Pérez S; Montejo AL; Caballero F; Caballero L; Arbesú JÁ; Delgado-Cohen H; Desaiah D; Polavieja P; Gilaberte I
J Affect Disord; 2010 Dec; 127(1-3):160-8. PubMed ID: 20541811
[TBL] [Abstract][Full Text] [Related]
6. [Association between fear of stigma, depressive and anxiety symptoms in patients with somatoform pain disorder].
Freidl M; Piralic-Spitzl S; Grohe N; Aigner M
Psychiatr Prax; 2012 Aug; 39(6):263-6. PubMed ID: 22926790
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study.
Jackson JL; Kroenke K
Psychosom Med; 2008 May; 70(4):430-4. PubMed ID: 18434494
[TBL] [Abstract][Full Text] [Related]
9. Late-life anxiety disorders among Puerto Rican primary care patients: impact on well-being, functioning, and service utilization.
Diefenbach GJ; Robison JT; Tolin DF; Blank K
J Anxiety Disord; 2004; 18(6):841-58. PubMed ID: 15474856
[TBL] [Abstract][Full Text] [Related]
10. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment.
Löwe B; Spitzer RL; Williams JB; Mussell M; Schellberg D; Kroenke K
Gen Hosp Psychiatry; 2008; 30(3):191-9. PubMed ID: 18433651
[TBL] [Abstract][Full Text] [Related]
11. Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior.
Rief W; Nanke A; Emmerich J; Bender A; Zech T
J Psychosom Res; 2004 Oct; 57(4):367-71. PubMed ID: 15518672
[TBL] [Abstract][Full Text] [Related]
12. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
Vaccarino AL; Evans KR; Sills TL; Kalali AH
Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
[TBL] [Abstract][Full Text] [Related]
13. [Determinants of quality of life in patients with somatoform disorders with pain as main symptom - the case for differentiating subgroups].
Nickel R; Hardt J; Kappis B; Schwab R; Egle UT
Z Psychosom Med Psychother; 2010; 56(1):3-22. PubMed ID: 20229488
[TBL] [Abstract][Full Text] [Related]
14. The frequency of the psychiatric symptoms in the patients with dyspepsia at a university hospital.
Guz H; Sunter AT; Bektas A; Doganay Z
Gen Hosp Psychiatry; 2008; 30(3):252-6. PubMed ID: 18433657
[TBL] [Abstract][Full Text] [Related]
15. [Because depression also hurts: duloxetine can help patients return to vitality].
MMW Fortschr Med; 2011 Apr; 153(14):76-7. PubMed ID: 21966877
[No Abstract] [Full Text] [Related]
16. The "repeater" phenomenon in migraine patients: a clinical and psychometric study.
Villani V; Di Stani F; Vanacore N; Scattoni L; Cerbo R; Bruti G
Headache; 2010 Mar; 50(3):348-56. PubMed ID: 20039961
[TBL] [Abstract][Full Text] [Related]
17. Overlap, comorbidity, and stability of somatoform disorders and the use of current versus lifetime criteria.
Leiknes KA; Finset A; Moum T; Sandanger I
Psychosomatics; 2008; 49(2):152-62. PubMed ID: 18354069
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update.
Lieb R; Meinlschmidt G; Araya R
Psychosom Med; 2007 Dec; 69(9):860-3. PubMed ID: 18040095
[TBL] [Abstract][Full Text] [Related]
19. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
Brown C; Schulberg HC; Shear MK
Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope.
D'Antono B; Dupuis G; St-Jean K; Lévesque K; Nadeau R; Guerra P; Thibault B; Kus T
J Psychosom Res; 2009 Sep; 67(3):213-22. PubMed ID: 19686877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
